Corporation name: Redacted ABN: Redacted Business trading name: Redacted Primary contact name: Redacted Primary contact numbers Business: Redacted Mobile: Redacted Email: Redacted Alternative contact name: Redacted Alternative contact numbers Business: Redacted Mobile: Redacted Email: Redacted (a) Are you a lobbyist acting on behalf of an Applicant? Yes No If yes, are you listed on the Register of Lobbyists? Yes No PART 2 – INFORMATION ABOUT THE PROPOSED MEDICAL SERVICE Application title Heritable mutations which increase risk in colorectal and endometrial cancer. Provide a succinct description of the medical condition relevant to the proposed service (no more than 150 words – further information will be requested at Part F of the Application Form) Familial adenomatous polyposis (FAP), juvenile polyposis syndrome (JPS), Lynch syndrome (formerly known as hereditary nonpolyposis colorectal cancer (HNPCC)), Peutz-Jeghers syndrome (PJS), hereditary mixed polyposis syndrome (HMPS) and autosomal recessive colorectal adenomatous polyposis polyposis or MAP) are all inheritable syndromes predisposing to colorectal and other epithelial cancers. Provide a succinct description of the proposed medical service (no more than 150 words – further information will be requested at Part 6 of the Application Form) Genetic testing should be considered in patients with a personal history of colorectal or endometrial cancer with potential hereditary genetic risk of >10% as assessed by their treating specialist. This would include: CRC with evidence of mismatch repair deficiency (MMR) and/or clinical evidence of a possible familial polyposis syndrome; and cascade testing of family members of patients identified with clinically actionable pathogenic mutations on the request of a medical specialist or clinical geneticist.
Corporation name: Redacted ABN: Redacted Business trading name: Redacted Primary contact name: Redacted Primary contact numbers Business: Redacted Mobile: Redacted Email: Redacted Alternative contact name: Redacted Alternative contact numbers Business: Redacted Mobile: Redacted Email: Redacted (a) Are you a lobbyist acting on behalf of an Applicant? Yes No If yes, are you listed on the Register of Lobbyists? Yes No PART 2 – INFORMATION ABOUT THE PROPOSED MEDICAL SERVICE Application title Heritable mutations which increase risk in colorectal and endometrial cancer. Provide a succinct description of the medical condition relevant to the proposed service (no more than 150 words – further information will be requested at Part F of the Application Form) Familial adenomatous polyposis (FAP), juvenile polyposis syndrome (JPS), Lynch syndrome (formerly known as hereditary nonpolyposis colorectal cancer (HNPCC)), Peutz-Jeghers syndrome (PJS), hereditary mixed polyposis syndrome (HMPS) and autosomal recessive colorectal adenomatous polyposis polyposis or MAP) are all inheritable syndromes predisposing to colorectal and other epithelial cancers. Provide a succinct description of the proposed medical service (no more than 150 words – further information will be requested at Part 6 of the Application Form) Genetic testing should be considered in patients with a personal history of colorectal or endometrial cancer with potential hereditary genetic risk of >10% as assessed by their treating specialist. This would include: CRC with evidence of mismatch repair deficiency (MMR) and/or clinical evidence of a possible familial polyposis syndrome; and cascade testing of family members of patients identified with clinically actionable pathogenic mutations on the request of a medical specialist or clinical geneticist.